Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation.

Saved in:
Bibliographic Details
Title: Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation.
Authors: Hsieh, Pei-Ling1 (AUTHOR), Chu, Pei-Ming2 (AUTHOR), Cheng, Hui-Ching3 (AUTHOR), Huang, Yu-Ting3 (AUTHOR), Chou, Wan-Ching3 (AUTHOR), Tsai, Kun-Ling3,4 (AUTHOR) kunlingtsai@mail.ncku.edu.tw, Chan, Shih-Hung5 (AUTHOR) kunlingtsai@mail.ncku.edu.tw
Source: International Journal of Molecular Sciences. Sep2022, Vol. 23 Issue 17, p10146. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms231710146